Potentially useful combinations of chemotherapy detected in mouse tumor systems.
D000111:Acetylcysteine / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D001380:Azauridine / Q000494:pharmacology / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D002166:Camptothecin / Q000627:therapeutic use; D003498:Cyclic P-Oxides / Q000494:pharmacology / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005021:Ethylamines / Q000494:pharmacology / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010078:Oxazines / Q000494:pharmacology / Q000627:therapeutic use; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011407:Propane / Q000494:pharmacology / Q000627:therapeutic use; D014226:Triazenes / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003498:Cyclic P-Oxides; D005021:Ethylamines; D007093:Imidazoles; D010078:Oxazines; D010879:Piperazines; D014226:Triazenes; D003561:Cytarabine; D001761:Bleomycin; D011344:Procarbazine; D001380:Azauridine; D003520:Cyclophosphamide; D011407:Propane; D005472:Fluorouracil; D000111:Acetylcysteine; D002166:Camptothecin; D008727:Methotrexate